News

One relatively safe bet about how Pfizer's lineup will look different five years from now is that the company will be a ...
Emerging therapies, including antibody-drug conjugates and biomarker-driven approaches, have the potential to significantly ...
Pfizer stands as one of the largest pharmaceutical companies in the world. Although it has an attractive 7.1% yield, it has a big blemish in its dividend past. Investors looking at drug stocks ...
The Justice Department changed its policy on foreign corruption cases, which might have put an end to investigations into the pharmaceutical company.
Shares of Pfizer offer a yield above 7% at recent prices. Pfizer is a pharmaceutical giant that has raised its dividend every year since 2009. Loss of patent-protected exclusivity for several ...
The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company delayed the results of COVID-19 vaccine trials to influence the 2020 election.
A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that there was a conspiracy among senior executives at the pharma company to “deliberately slow down&#822… ...
The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an allegation that clinical testing related to the development of the ...
Pfizer has added another chapter to its long-running drug discovery collaboration with Chinese tech startup XtalPi, this time upgrading their molecular modeling work. The aim is to help “grasp ...